Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2019

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Biomedtracker: Early Outlook Report 2019

Download report

Q1 Outlook Webinar - Key catalysts and their impact on pharma markets

Q1 Outlook 2019 Webinar - 27 February 2019 - Key Catalysts and their Impact on Pharma Markets

Discover more

Find out more

Whitepaper: Taking the 'High' out of Pain

Download today

Welcome to your Pharma Intelligence advantage

Market intelligence

We’re the world’s leading provider of drug, device, company, clinical trial and market intelligence in the competitive pharma and medtech markets.

News and insight

We provide unrivalled and daily-updated global insight, drawn from extensive authoritative data sets and enriched by human validation.

Data and analytics

Our premium quality data is drawn from 42,000 companies, 248,000 clinical trials in 175 countries and 65,000 drugs for 1,400 diseases.

Consultancy

Our bespoke clinical, commercial and market access solutions are designed to help you make smarter decisions that bring a better return on investment.

Global industry experts

Working in an interconnected global network, our 65 journalists and over 300 in-house analysts supply comprehensive analysis and reports.

Trusted partnerships

We’re the trusted partner of more than 3,000 companies including the top 50 pharma firms and top 10 contract research organizations.

Gold-standard service

Our customer services team will support you every step of the way so that our insight, intelligence and bespoke solutions match your needs.

Tailor-made solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round your exact needs.

Our Specialties

Clinical trial intelligence

Gain a competitive edge with comprehensive clinical trial intelligence. Find out what competitors are doing in key areas, understand regulations, view clinical trial and program timelines, identify sites and investigators.

Competitive and market intelligence

See the entire global biopharma and medtech market landscape in one place – our expert analysis and trusted databases cover all sectors of the industry.

business development licensing pharma intelligence

Business development and licensing

Get coverage of the latest pharmaceutical business developments, and historical metrics on financing, licensing, partnership, and acquisition.

business portfolio strategy pharma intelligence

Pharmaceutical portfolio strategy

Identify M&A targets and partnership opportunities, and develop business cases with our real-time intelligence, tools and analysis.

Regulatory approval

An increasingly complex regulatory framework for the pharmaceutical, biotech and medtech industries presents growing challenges to businesses. We’ll help you stay ahead.

medtech competitive intelligence pharma intelligence

Medtech market intelligence

To succeed in medtech, you need to have your finger on the pulse – we’ll help you access the accurate, reliable information you need.

View more
View Less

Our trusted Pharma Intelligence brands

Biomedtracker, Meddevicetracker

Biomedtracker: Early 2019 Outlook Report

20 Feb 2019

In this report, we cover catalysts from 23 drugs, devices and diagnostics expected to occur in early 2019.

Topic Drug approval Drug review Medtech

Single report
Scrip, Pink Sheet

Webinar: What’s the Reality of Real World Evidence?

By Mary Jo Laffler 19 Feb 2019

The data and analysis for this webinar were drawn from Pink Sheet and Scrip, both part of the Informa Pharma Intelligence suite of intelligence solutions.

Full video
HBW Insight

France's OTC Market in 2018: Self-Medication Sales Slump, Sanofi Claims Number-One Spot

14 Feb 2019

France's self-medication market had a difficult 2018, due to a weak flu season and changing dynamics in the sector, according to industry association Afipa. Despite this it was a good year for Sanofi, which overtook Boiron as the number-one OTC firm in the market, while its Doliprane analgesic became France's best-selling brand.

Topic Drug review

View article
Generics Bulletin

Alvogen Claims Lead On Lenalidomide In Europe

14 Feb 2019

Alvogen is claiming the first European launch of a generic rival to Revlimid, rolling out the oncology drug in several central and eastern European markets. Meanwhile, IPR challenges to three Revlimid patents in the US have been denied.

Topic Drug review

View article
Pink Sheet

Big Pharma CEOs Get Ready To Testify Preparing For A No Win Situation

By Michael McCaughan 14 Feb 2019

Here is what to expect from – and some free advice for – seven industry executives as they prepare for a hearing on drug pricing in the Senate Finance Committee.

Topic Drug approval

View article
Medtech Insight

New Device Tax Repeal Bills Are Coming, With Candidate Klobuchar's Help

By Ferdous Al-Faruque 14 Feb 2019

Despite a recent report that Sen. Amy Klobuchar, D-Minn., is backing away from leading efforts to repeal the medical device tax due to her presidential ambitions, sources say she is working with Sen. Pat Toomey, R-Pa., to cosponsor a repeal bill this year. Similarly, on the US House-side, Rep. Ron Kind, D-Wisc., is calling on his colleagues to support a full repeal bill as well.

Topic Medtech

View article
Medtech Insight

One In Three Medtech Innovators Will Be 'Driven Out Of Business' By EU MDR, German Business Survey Finds

By Ashley Yeo 14 Feb 2019

The EU Medical Device Regulation is 15 months away from being implemented in full, and a new German survey about its potential impact on the medtech innovation and patient-care landscape makes for sobering reading.

Topic Medtech

View article
Scrip

In NASH, Gilead Swung For The Fences And Struck Out Again

By Joseph Haas 14 Feb 2019

Gilead took a risky approach with selonsertib in NASH, pursuing a tough liver fibrosis benefit and failing, continuing a trend of disappointments outside of its antiviral franchises. Analysts don’t expect the second Phase III study in less-sick patients to succeed either.

Topic Drug review Drug approval Drug development landscape Clinical trials

View article
Scrip

Keytruda/Inlyta Data Stoke Competition In Kidney Cancer

By John Davis 14 Feb 2019

Competing combination therapies may soon be battling for attention as first-line therapies for advanced or metastatic renal cell carcinoma, with Merck & Co being the latest big pharma to release more data on the Keytruda/Inlyta combo in the setting.

Topic Cancer

View article
Pink Sheet

US Initiative To End HIV Epidemic Will Boost PrEP Access

By Brenda Sandburg 07 Feb 2019

'Number of different initiatives' coming in next several months to make drugs more affordable, including for PrEP prophylaxis, HHS Assistant Secretary for Health Giroir says. Multi-agency approach is key strategy.

Topic Drug approval Drug development landscape Drug review

View article
Medtech Insight

BSI Touts Very Short Waiting Times For Migrating Certificates From UK To Netherlands

By Amanda Maxwell 07 Feb 2019

With a growing urgency for medtech manufacturers to take decisive action so their products are not banned from the market under an increasingly likely no-deal Brexit, clients of BSI will be relieved to hear their notified body believes time is on their side.

Topic Medtech

View article
Medtech Insight

US Homeland Security: Stryker, BD Devices Pose Hacking Risk

By Elizabeth Orr 07 Feb 2019

The US Department of Homeland Security National Cybersecurity and Communications Integration Center is warning of potential cybersecurity vulnerabilities in Stryker hospital beds and BD diagnostics equipment.

View article
Scrip

Novartis Pharma CEO Sees Zolgensma Supplanting Spinraza

07 Feb 2019

The Swiss major's pharma chief tells Scrip that its gene therapy for SMA offers much more than Biogen's Spinraza for both patients and payers, noting that the company is ready with alternative payment models for the pricey treatment as soon as approvals for Zolgensma are granted.

Topic Business strategies Drug approval Drug development landscape Drug review

View article
Scrip

Roche Makes Case For Its Oral SMA Drug Risdiplam As Filings Beckon

By Alexandra Shimmings 07 Feb 2019

Novartis may be turning up the rhetoric in spinal muscular atrophy as its cutting-edge gene therapy Zolgensma approaches a market currently enjoyed solely by Biogen’s Spinraza, but Roche is upbeat about the potential of its investigational oral product, risdiplam, to weigh in.

Topic Business strategies Drug approval Drug development landscape

View article
Primal Pictures

Achieving Competitive Advantage With Anatomy And Physiology

04 Feb 2019

This whitepaper explores how best in class anatomy, physiology and clinical content, images and customized solutions enable organizations to achieve strong competitive advantage, drive credibility, productivity and differentiation. We will share ideas that you can consistently apply to your own organization to reach business and revenue goals. Finally, we will conclude with a checklist of what to look for when selecting your anatomy content solution.

View white paper

Latest headlines

Medtech Insight

20 Feb 2019

QUOTED. Feb. 20, 2019. Karl Vahey.

Link
In Vivo

20 Feb 2019

Deal-Making Fires Up To Unlock Checkpoint Inhibitors’ Full Potential

Link
In Vivo

20 Feb 2019

Biopharma Quarterly Dealmaking Statistics, Q4 2018

Link
Medtech Insight

20 Feb 2019

Spinal Implants: Finding A Manageable Regulatory Pathway Through Complex EU MDR Wording

Link
Scrip

19 Feb 2019

Pioneering Gyroscope Therapeutics Aims To Develop One-Time Gene Therapy For AMD

Link
Scrip

19 Feb 2019

Facing Up To A Patent Cliff: Indivior Plans For Loss of Suboxone Film Exclusivity

Link
Medtech Insight

19 Feb 2019

QUOTED. Feb. 19, 2019. Walton Taylor.

Link
Scrip

19 Feb 2019

IQVIA Could Be CRO Bellwether As Tech Offering Outperforms Expectations

Link
Medtech Insight

19 Feb 2019

MDx Health Names New CEO

Link
Pink Sheet

19 Feb 2019

How One Biotech Venture Is Breaking The Cost Barrier In Manufacturing MAbs For Infectious Diseases

Link
Scrip

19 Feb 2019

Merck's Keytruda Loss In Liver Cancer Could Be Gain For Rivals

Link
Scrip

19 Feb 2019

Cipla Backs Start-Up As It Builds Digital Health Strategy

Link
Pink Sheet

19 Feb 2019

Can Government Petition PTAB To Review Patents? Supreme Court Seems Skeptical

Link
Scrip

19 Feb 2019

Nektar/Bristol Show Promise With Double IO Combo, But Numbers Are Small

Link
Pink Sheet

19 Feb 2019

Rare Pediatric Disease Priority Review Voucher Not Generating New Drug Trials

Link

Featured products

Trialtrove: gold standard clinical trials intelligence

Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.

Key benefits:

Curated by experts
Clinical trial landscape view
Standard of care insights

Datamonitor Healthcare: data analysis and insight

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

Key benefits:

Prioritize market opportunities
Identify unmet needs
Make informed decisions

Scrip: industry news and insights

Key benefits:

Follow market developments
Go beyond the news
Hear from news makers

Upcoming events

Webinar

Q1 Outlook Webinar - Key catalysts and their impact on pharma markets

Presenters:

Dominique Fontanilla
Michael Haydock

Texas , USA

Industry conference

ER&L Conference

Awards

OTC Marketing Awards

View All Events

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Biomedtracker: Early Outlook Report 2019

Q1 Outlook 2019 Webinar - 27 February 2019 - Key Catalysts and their Impact on Pharma Markets

Whitepaper: Taking the 'High' out of Pain

Welcome to your Pharma Intelligence advantage

Below are the Feature List

Market intelligence

News and insight

Data and analytics

Consultancy

Global industry experts

Trusted partnerships

Gold-standard service

Tailor-made solutions

Our Specialties

Pharma Intelligence latest insights

Latest headlines

Featured products

Below are the Product Brand List

Trialtrove: gold standard clinical trials intelligence

Datamonitor Healthcare: data analysis and insight

Scrip: industry news and insights

Upcoming events

Q1 Outlook Webinar - Key catalysts and their impact on pharma markets

ER&L Conference

OTC Marketing Awards

Keep up to date

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Pharma Report Store